Directif Partners with Epidauros to Market
Its LabChip for Clinical Diagnostics

Directif GmbH and Epidauros Biotechnology have signed a co-development and co-marketing agreement for Directif's LabChip technology, the firms said last week.

Epidauros, a provider of pharmacogenetic assays and services, will partner with Directif, a subsidiary of November AG based in Erlangen, Germany, to create "client-specific" applications for the LabChip technology, which offers automated analysis of nucleic acids for clinical diagnostic applications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.